Meet Eric
Eric Adam has 25 years of experience in managing strategic alliances, partnerships, and operations within the pharmaceutical and diagnostics industries. As the Global Head of Operations for Neuroscience and Rare Diseases at ROCHE, Eric played a crucial role in growing the neurosciences portfolio. He led successful partnerships and drug discovery initiatives, refined neuroscience asset prioritization, enhanced leadership structures, decision-making processes, and team performance. His career includes roles at Otsuka Pharma, Athelas SA, and entrepreneurial ventures on Biosafetys and Syrrx. Dr. Adam joined the founding teams of three organizations focused on antimicrobial resistance, including two biotechnology start-ups and a non-profit promoting access to essential medical care in developing countries. These efforts highlight his entrepreneurial spirit and commitment to global health challenges.
As Chief Operations Officer (COO) at HAYA Therapeutics, Eric oversees operations, facilitates scalable growth across departments, enhances technological infrastructure, and supports the development of strategic partnerships and business ideas.
